ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 249 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $340,067 | +728.6% | 16,318 | +533.0% | 0.00% | – |
| Q4 2022 | $41,042 | -71.9% | 2,578 | -75.2% | 0.00% | – |
| Q2 2022 | $146,000 | -92.7% | 10,390 | -87.9% | 0.00% | -100.0% |
| Q4 2021 | $2,000,000 | -6.6% | 85,687 | -33.6% | 0.01% | -22.2% |
| Q3 2021 | $2,142,000 | -76.2% | 128,978 | -40.8% | 0.01% | -86.4% |
| Q3 2020 | $8,987,000 | +2277.5% | 217,864 | +2696.0% | 0.07% | +2100.0% |
| Q2 2020 | $378,000 | -70.4% | 7,792 | -90.1% | 0.00% | -66.7% |
| Q4 2018 | $1,275,000 | -95.3% | 78,845 | -94.0% | 0.01% | -92.6% |
| Q3 2018 | $26,907,000 | +29.7% | 1,311,076 | -3.5% | 0.12% | +29.8% |
| Q2 2018 | $20,749,000 | +27.5% | 1,358,793 | +87.5% | 0.09% | +38.2% |
| Q1 2018 | $16,280,000 | +51.0% | 724,500 | +102.4% | 0.07% | +100.0% |
| Q4 2017 | $10,778,000 | +32.5% | 357,958 | +22.7% | 0.03% | +3.0% |
| Q2 2017 | $8,137,000 | -34.8% | 291,745 | -32.6% | 0.03% | -50.7% |
| Q4 2016 | $12,479,000 | +4356.8% | 432,691 | +4226.9% | 0.07% | +3250.0% |
| Q1 2016 | $280,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |